Form 4: Prestige Consumer Healthcare Executive Acquires Shares Through Restricted Stock Units

Adel Mekhail, EVP of Marketing & Sales at Prestige Consumer Healthcare, acquired 3,020 shares of common stock through restricted stock units on May 7, 2024.

Summary

• On May 7, 2024, Adel Mekhail, the EVP of Marketing & Sales at Prestige Consumer Healthcare Inc., acquired 3,020 shares of common stock.
• The acquisition was made through restricted stock units (RSUs).
• The price per share was $0.
• Following the transaction, Mekhail directly owns 21,863 shares of Prestige Consumer Healthcare Inc.
• The restricted stock units vest in three installments: 1,006 shares on May 7, 2025, and 1,007 shares each on May 7, 2026 and 2027.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects a routine transaction related to executive compensation. The acquisition of shares by an executive is generally viewed as a positive sign, but it's not a major event that would significantly impact sentiment.

Positives

• The acquisition of shares by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

Form 4 filings are routine disclosures required by the SEC when company insiders, like executives, trade their company's stock. These filings provide transparency into insider transactions and can be used by investors to gauge management's sentiment towards the company's prospects.

Stakeholder Impact

• The acquisition of shares by a company executive can have a minor positive impact on shareholder confidence.

Key Dates